Fig. 3.
Fig. 3. LT-HSC from BM and blood of CY/G-CSF–treated animals express cyclin D2 mRNA. / (A) Splenic T cells, (B) CY/G-CSF day +4 LT-HSC from BM, and (C) CY/G-CSF day +4 MPB LT-HSC. Cells were double sorted into lysis buffer in 96-well plates at 5 cells/well, followed by RT and nested PCR for cyclin D2 (35 cycles per primer pair; see “Materials and methods”). PCR products of the predicted length (331 bp) were obtained. Reverse transcriptase (RT) was omitted from samples in lanes 11 and 12.

LT-HSC from BM and blood of CY/G-CSF–treated animals express cyclin D2 mRNA.

(A) Splenic T cells, (B) CY/G-CSF day +4 LT-HSC from BM, and (C) CY/G-CSF day +4 MPB LT-HSC. Cells were double sorted into lysis buffer in 96-well plates at 5 cells/well, followed by RT and nested PCR for cyclin D2 (35 cycles per primer pair; see “Materials and methods”). PCR products of the predicted length (331 bp) were obtained. Reverse transcriptase (RT) was omitted from samples in lanes 11 and 12.

Close Modal

or Create an Account

Close Modal
Close Modal